Wire · regulatory
SEC and FDA Sign Memorandum of Understanding Regarding Information Sharing
◆ Sectors
Biotech
◆ Geography
United States
◆ Source
◆ Verified
Fusion42 · 5 September 2026 · Fusion42 review
The SEC and FDA have signed a memorandum of understanding to share nonpublic information related to FDA-regulated products, enhancing SEC oversight of life science companies' public disclosures about FDA interactions.
This Wire brief sits within Fusion42's coverage of Biotech.
◆ ◆ The Wire takeaway
Your life science company's investor communications now face direct FDA scrutiny through SEC collaboration. Tighten your disclosure controls this week to avoid costly compliance hits and SEC investigations.
◆ Coverage
1 source · 5 Sep 2026
◆ Related on Wire
◆ Topics
Biotechsec-fda-moulife-sciencesregulatory-compliancepublic-disclosuresinformation-sharing